BioCentury
ARTICLE | Company News

KaloBios management update

August 12, 2013 7:00 AM UTC

KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. Business: Antibodies, Infectious, Inflammation Retiring: Jeffrey Cooper as CFO, effective Dec. 31 ...